Y-mAbs Therapeutics (YMAB) Stock Chart & Stock Price History → Dems have chosen Biden replacement? (From Paradigm Press) (Ad) Free YMAB Stock Alerts $12.10 +0.09 (+0.75%) (As of 05/31/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Y-mAbs Therapeutics Stock Price Performance5 Day Performance-0.98%1 Month Performance-26.62%3 Month Performance-35.26%6 Month Performance+96.43%Year-To-Date Performance+77.42%1 Year Performance+55.53% Receive YMAB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Y-mAbs Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad The Freeport SocietyBiden Nomination CANCELED?The Hill just published that Joe Biden has received enough delegates to…“clinch the Democratic presidential nomination and all but guaranteeing he will face off against former President Trump again in November.” Why is he all BUT guaranteed the Democratic nomination, in their words?I believe I have the terrifying answer right here. YMAB Stock Chart for Sunday, June, 2, 2024 YMAB Chart by TradingView Y-mAbs Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/31/2024$12.01$12.10+0.75%$12.42$11.87902,462 shs$530.95 million05/30/2024$12.27$12.01-2.12%$12.22$11.79355,127 shs$527.00 million05/29/2024$12.14$12.27+1.07%$12.33$11.81473,588 shs$538.44 million05/28/2024$12.22$12.14-0.65%$12.76$12.05207,111 shs$532.70 million05/27/2024$12.22$12.22$12.60$12.08148,600 shs$536.21 million05/24/2024$12.40$12.22-1.45%$12.59$12.08148,667 shs$536.25 million Get the Latest News and Ratings for YMAB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Y-mAbs Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/23/2024$12.85$12.40-3.50%$13.02$12.32246,556 shs$544.11 million05/22/2024$12.56$12.85+2.31%$13.25$12.42564,353 shs$563.86 million05/21/2024$11.82$12.56+6.26%$12.59$11.76311,378 shs$551.13 million05/20/2024$11.60$11.82+1.90%$11.88$11.15365,847 shs$518.66 million05/17/2024$11.85$11.60-2.11%$12.02$11.50379,936 shs$509.01 million05/16/2024$12.18$11.85-2.71%$12.39$11.74207,629 shs$519.98 million05/15/2024$11.82$12.18+3.05%$12.75$12.03267,473 shs$534.46 million05/14/2024$12.19$11.82-3.04%$12.70$11.52426,921 shs$518.66 million05/13/2024$12.28$12.19-0.73%$12.55$11.83543,174 shs$534.90 million05/10/2024$12.87$12.28-4.58%$12.96$11.91488,643 shs$538.76 million05/09/2024$13.61$12.87-5.44%$14.44$12.75631,882 shs$564.61 million05/08/2024$17.21$13.61-20.92%$15.54$12.901.59 million shs$597.07 million05/07/2024$17.24$17.21-0.17%$17.47$16.98386,559 shs$755.00 million05/06/2024$17.15$17.24+0.52%$17.38$16.80206,141 shs$756.32 million05/03/2024$17.25$17.15-0.58%$17.78$16.99246,023 shs$752.37 million05/02/2024$16.49$17.25+4.61%$17.39$16.30376,466 shs$756.76 million05/01/2024$15.21$16.49+8.42%$17.00$15.36365,227 shs$721.93 million04/30/2024$15.50$15.21-1.87%$15.56$14.98214,271 shs$665.89 million04/29/2024$14.71$15.50+5.37%$15.57$14.65158,043 shs$678.59 million04/26/2024$14.84$14.71-0.88%$15.13$14.36189,746 shs$644.00 million04/25/2024$15.29$14.84-2.94%$15.44$14.28365,385 shs$649.65 million04/24/2024$15.34$15.29-0.33%$15.46$15.02158,213 shs$669.40 million04/23/2024$15.16$15.34+1.19%$16.39$14.90513,319 shs$671.59 million04/22/2024$15.13$15.16+0.20%$15.86$14.96472,659 shs$663.71 million04/19/2024$15.00$15.13+0.87%$15.41$14.71467,186 shs$662.39 million04/18/2024$15.11$15.00-0.73%$15.46$14.82410,152 shs$656.70 million04/17/2024$15.14$15.11-0.20%$15.41$14.89450,529 shs$661.52 million04/16/2024$14.91$15.14+1.54%$15.69$14.50442,474 shs$662.83 million04/15/2024$14.37$14.91+3.76%$14.95$14.21297,629 shs$652.76 million04/12/2024$14.63$14.37-1.78%$14.68$14.06237,905 shs$629.12 million04/11/2024$13.79$14.63+6.09%$14.82$13.91246,933 shs$640.46 million04/10/2024$14.07$13.79-1.99%$14.00$13.34375,827 shs$603.73 million04/09/2024$14.45$14.07-2.63%$14.57$13.85186,297 shs$615.99 million04/08/2024$14.46$14.45-0.07%$14.87$14.02168,443 shs$632.62 millionWhat is Nvidia doing on June 10? June 10th is pivotal for Nvidia’s “Silent Partners” (Ad)A small handful of companies are working with Nvidia to help ensure that this pivot is a massive success. We call them Nvidia’s “Silent Partners.”Click here to find out who they are.04/05/2024$14.56$14.46-0.69%$15.08$14.34436,698 shs$633.06 million04/04/2024$14.42$14.56+0.97%$14.92$14.27288,136 shs$637.44 million04/03/2024$14.76$14.42-2.30%$14.74$13.95349,224 shs$631.31 million04/02/2024$16.19$14.76-8.83%$15.63$14.28411,126 shs$646.19 million04/01/2024$16.26$16.19-0.43%$17.49$15.78650,879 shs$708.75 million03/29/2024$16.26$16.26$16.50$15.94270,332 shs$711.86 million03/28/2024$16.50$16.26-1.45%$16.50$15.94270,332 shs$711.86 million03/27/2024$15.70$16.50+5.10%$16.53$15.32172,284 shs$722.37 million03/26/2024$15.71$15.70-0.06%$16.33$15.63183,315 shs$687.30 million03/25/2024$16.23$15.71-3.20%$16.64$15.45309,482 shs$687.78 million03/22/2024$16.94$16.23-4.19%$17.17$16.22338,785 shs$710.55 million03/21/2024$15.49$16.94+9.36%$17.26$15.74372,379 shs$741.58 million03/20/2024$14.89$15.49+4.03%$15.56$14.50288,595 shs$678.15 million03/19/2024$13.76$14.89+8.21%$15.86$13.76740,211 shs$651.88 million03/18/2024$14.70$13.76-6.39%$14.74$13.71357,821 shs$602.41 million03/15/2024$15.00$14.70-2.00%$15.23$14.58452,497 shs$643.57 million03/14/2024$15.84$15.00-5.30%$15.46$14.41308,164 shs$656.70 million03/13/2024$16.09$15.84-1.55%$16.33$15.70190,254 shs$693.48 million03/12/2024$16.49$16.09-2.43%$16.96$16.01188,388 shs$704.37 million03/11/2024$17.62$16.49-6.41%$17.39$15.39325,824 shs$721.93 million03/08/2024$17.64$17.62-0.11%$18.11$17.11211,285 shs$771.40 million03/07/2024$17.99$17.64-1.95%$18.17$17.45142,077 shs$772.23 million03/06/2024$16.64$17.99+8.11%$18.19$17.12340,923 shs$787.60 million03/05/2024$17.33$16.64-3.98%$17.29$16.34298,231 shs$728.50 million03/04/2024$18.69$17.33-7.28%$19.12$17.32460,853 shs$758.71 million03/01/2024$16.70$18.69+11.92%$20.90$18.251.26 million shs$815.26 million02/29/2024$16.33$16.70+2.27%$17.03$16.44320,276 shs$728.45 million Related Companies: ALT Stock Chart CMPS Stock Chart SIGA Stock Chart AVTE Stock Chart CDMO Stock Chart OLMA Stock Chart HROW Stock Chart HRTX Stock Chart TRDA Stock Chart SVRA Stock Chart Receive YMAB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Y-mAbs Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:YMAB) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersBiden Nomination CANCELED?The Freeport SocietyWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Y-mAbs Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.